Spectrum Pharmaceuticals Inc
SPPI
SPPI was delisted on the 31st of July, 2023.
156 hedge funds and large institutions have $389M invested in Spectrum Pharmaceuticals Inc in 2021 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 67 increasing their positions, 34 reducing their positions, and 12 closing their positions.
97% more repeat investments, than reductions
Existing positions increased: 67 | Existing positions reduced: 34
83% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 12
18% more capital invested
Capital invested by funds: $330M → $389M (+$59.5M)
6% more funds holding
Funds holding: 147 → 156 (+9)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
72% less call options, than puts
Call options by funds: $411K | Put options by funds: $1.47M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$7.02M |
| 2 |
Morgan Stanley
New York
|
+$4.48M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.5M |
| 4 |
Two Sigma Investments
New York
|
+$2.47M |
| 5 |
JAM
Jupiter Asset Management
London,
United Kingdom
|
+$1.57M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
-$6.7M |
| 2 |
Renaissance Technologies
New York
|
-$4.96M |
| 3 |
California Public Employees Retirement System
Sacramento,
California
|
-$956K |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$843K |
| 5 |
Rafferty Asset Management
New York
|
-$771K |
SPPI Hedge Fund Activity: Q2 2021 in Review
156 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Spectrum Pharmaceuticals Inc (SPPI) for Q2 2021, worth a combined $389M — up 18% from $330M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new SPPI positions and 12 closed out — a net gain of 10 holders — while 67 added to existing stakes and 34 trimmed.
The largest buyer was BlackRock, adding an estimated $7.02M. The largest seller was State Street, cutting an estimated $6.7M.
- 156 institutional investors held Spectrum Pharmaceuticals Inc (SPPI) as of Q2 2021, up from 147 in Q1 2021.
- Funds reported $389M of Spectrum Pharmaceuticals Inc stock for Q2 2021, up 18% quarter-over-quarter.
- 22 funds opened new Spectrum Pharmaceuticals Inc positions in Q2 2021 and 12 closed out, a net change of +10 holders.
- The largest Spectrum Pharmaceuticals Inc buyer in Q2 2021 was BlackRock, an estimated $7.02M added.
- The largest Spectrum Pharmaceuticals Inc seller in Q2 2021 was State Street, an estimated $6.7M sold.
Based on aggregated 13F filings for Q2 2021.